Data Under Review
Some valuation figures for this stock are being recalibrated. Hidden fields will return after data review.
Reported as ticker: PANACEABIO· We're continuously improving data quality. Contact support if this persists.
PANACEA BIOTEC LTD
PANACEABIO · General/Diversified · NSE
₹369
Current Market Price
Fair Value (DCF)
₹0
Margin of Safety
-100.0%
Updated just now
YieldIQ Score
30/100
Piotroski F-Score
3/9
Economic Moat
Narrow
Confidence
1342500020%
ROE
—
Debt/Equity
0.03
WACC
11.1%
Market Cap
₹2,257 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
—
Return on capital employed
EV / EBITDA
—
Enterprise multiple
Debt / EBITDA
—
Leverage vs earnings
Interest Coverage
-1.7×
EBIT covers interest
Current Ratio
1.49×
Short-term liquidity
Asset Turnover
0.38×
Revenue per ₹ of assets
Revenue CAGR (3Y)
-9.3%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹368.55
Bear case
₹0
MoS -Infinity%
Base case
₹0
MoS -Infinity%
Bull case
₹0
MoS -Infinity%
Ratio Trends
PANACEABIO · last 8 annual periods
ROE
-1.0%
ROCE
3.5%
Operating Margin
—
Debt / Equity
0.02×
PE
0.7×
EV / EBITDA
11.2×
Historical Financials
PANACEABIO · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹625 Cr | ₹661 Cr | ₹457 Cr | ₹552 Cr | ₹493 Cr | -5.8% |
| EBITDA | — | ₹1673 Cr | ₹55.7 Cr | ₹40.9 Cr | ₹29.8 Cr | -63.5% |
| EBIT | ₹41.0 Cr | ₹1789 Cr | ₹19.3 Cr | ₹-1.3 Cr | — | — |
| PAT | ₹-148 Cr | ₹1237 Cr | ₹-12.7 Cr | ₹-2.0 Cr | ₹-8.4 Cr | — |
| EPS (diluted) | ₹-23.87 | ₹202.03 | ₹-2.07 | ₹-0.23 | — | — |
| CFO | ₹107 Cr | ₹-108 Cr | ₹-423 Cr | ₹3.5 Cr | ₹-27.4 Cr | — |
| CapEx | — | — | — | — | ₹-50.3 Cr | — |
| FCF | — | — | — | — | ₹-77.7 Cr | — |
| Total Assets | — | ₹1759 Cr | ₹1271 Cr | ₹1241 Cr | ₹1290 Cr | -7.5% |
| Total Debt | — | — | ₹0.1 Cr | ₹0.0 Cr | ₹15.0 Cr | +297.6% |
| Shareholders' Equity | — | — | ₹844 Cr | ₹842 Cr | ₹831 Cr | -0.4% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
PANACEABIO vs 2 closest peers by market-cap band
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for PANACEABIO in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of PANACEABIO →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for PANACEABIO →
Compare
Head-to-head with peers
Compare PANACEABIO side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse PANACEABIONow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.